In this mouse model of atherosclerosis, both compounds appear to act through the same mechanisms, i.e., by preventing oxidation and the subsequent inactivation and degradation of MKP-1 [41,42], a master regulator of monocyte and macrophage function. This evidence concerns the gene DUSP1 and atherosclerosis.